APM-E - Metabolic Monitoring for Children and Adolescents on Antipsychotics
Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) is retired, only APM-E measure will be reported.
Product Lines:
EHP, Priority Partners and USFHP.
Eligible Population:
Members between 1 - 17 years of age as of December 31 of the measurement year.
Definition:
The percentage of members 1-17 years of age who had two or more antipsychotic prescriptions and had metabolic testing.
Three rates are reported (#3 is Accreditation for Commercial and Medicaid):
- Percentage of children and adolescents on antipsychotics who received blood glucose testing.
- Percentage of children and adolescents on antipsychotics who received cholesterol testing.
- Percentage of children and adolescents on antipsychotics who received blood glucose and cholesterol testing.
Continuous Enrollment:
- The measurement year.
Best Practice and Measure Tips
- Members who received both of the following during the measurement year on the same or different dates of service:
- At least one test for blood glucose or HbA1c and at least one test for LDL-C or cholesterol.
- If the medications are dispensed on different dates, even if it is the same medication, test both blood glucose with either a glucose or HbA1c test, and cholesterol with either a cholesterol or an LDL-C test.
- Measure baseline lipid profiles, fasting blood glucose level and body mass index.
- Ordering a blood glucose and cholesterol test every year and building care gap alerts in the electronic medical record.
- Testing blood glucose and cholesterol at a member’s annual checkup or school physical to reduce additional visits.
- Educate members and caregivers about the:
- Increased risk of metabolic health complications from antipsychotic medications.
- Importance of screening blood glucose and cholesterol levels.
- Behavioral health providers:
- Ordering blood glucose and cholesterol screening tests for members who do not have regular contact with their PCP and within 1 month of changing a member’s medication.
Measure Exclusions
Required Exclusion:
- Members in hospice or using hospice services anytime during the measurement year.
- Members who died any time during the measurement year.
Measure Codes
Need both an A1C or GLUCOSE and LDL-C or CHOLESTEROL.
- Blood Glucose
- HbA1C Lab Tests
- CPT: 83036, 83037
- CPT-CAT-II: 3044F, 3046F, 3051F, 3052F
- LOINC: 17855-8, 17856-6, 4548-4, 4549-2, 96595-4
- Glucose Lab Tests
- CPT: 80047, 80048, 80050, 80053, 80069, 82947, 82950, 82951
- LOINC: 10450-5, 1492-8, 1494-4, 1496-9, 1499-3, 1501-6, 1504-0, 1507-3, 1514-9, 1518-0, 1530-5, 1533-9, 1554-5, 1557-8, 1558-6, 17865-7, 20436-2, 20437-0, 20438-8, 20440-4, 2345-7, 26554-6, 41024-1, 49134-0, 6749-6, 9375-7
- HbA1C Lab Tests
- Cholesterol
- LDL-C Lab Tests
- CPT: 80061, 83700, 83701, 83704, 83721
- CPT-CAT-II: 3048F, 3049F, 3050F
- LOINC: 12773-8, 13457-7, 18261-8, 18262-6, 2089-1, 49132-4, 55440-2, 96259-7
- Cholesterol Lab Test
- CPT: 82465, 83718, 83722, 84478
- LOINC: 2085-9, 2093-3, 2571-8, 3043-7, 9830-1
- LDL-C Lab Tests
Measure Medications
Antipsychotic MedicationsDescription | Prescription |
---|---|
Miscellaneous antipsychotic agents |
|
Phenothiazine antipsychotics |
|
Thioxanthenes |
|
Long-acting injections |
|
Description | Prescription |
---|---|
Psychotherapeutic combinations |
|
Description | Prescription |
---|---|
Phenothiazine antipsychotics |
|